SH2B3 Gene Curation
Gene-disease assertions not curated here (add link or write note):
Disease | SH2B3-related myeloproliferative neoplasms |
---|---|
Inheritance | Autosomal dominant |
Prevalence | MDS in general is about 4.4 to 4.6 cases per 100,000 people |
Rapid or full curation? | Rapid Full |
| |
Clinical Validity Scoring Notes and points | Variant/Case Evidence: PMID 32641076 c.1A > G variant found in one individual with unexplained hemolysis by WES. This could potentially be on the spectrum of myeloproliferative disorder (1 pt) PMID 31173385 c.1198G>A, p.E400K variant found in an individual with features of MDS/MPN-overlap syndrome. Variant present in gnomAD v4 AF=0.18% (European chromosomes) so no points given. PMID 31102422 c.1261C>T p.Arg421Trp variant identified in individual with ALL (no points for inconsistent phenotype) PMID 24092923 Consanguineous family with c.671insGGCCCCG p. Asp231Glyfs*38 with autoimmune disorders and acute lymphoblastic leukemia (ALL). Does not match cell lineage or inheritance patterns (no points)
PMID 26457647- Cohort of JMML, multiple somatic in SH2B3. One germline variant p.E400K. No points due to high frequency Segregation Evidence: Case/Control Evidence: Experimental Evidence: Source: |
Clinical Validity Points Total |
Source: |
Clinical Validity Classification Definitive (12pts) Strong (12pts) Moderate (7-11pts) Limited (0.1-6pts) No genetic evidence Refuted Disputed | Limited Source: |
Molecular Mechanism Loss of function Gain of function Dominant negative Unknown Other | Loss of function / Gain of function / Dominant Negative
|
Penetrance Complete (100%) High (≥80%) Moderate (<80% and >20%) Low (≤20%) (list source/PMID) |
Source: |
Age of Onset Congenital Pediatric Adolescent Adulthood Late adulthood (list source/PMID) |
|
Severity |
|
Clinical Features |
Sources: |
HPO Terms |
|
Gene SOPs & Notes | LINK if SOP is a long document. Short notes if it is easy to digest. eg. Last known truncating variant |
Curation Summary |
|
Case ID, Curator name, Date, Jira ticket link |
|